Patients

Understanding
Your Cancer

You Deserve Answers. We’re Here to Help You Get Them. Predicta’s blood-based testing gives your doctor a clearer picture of your multiple myeloma – so you can get the right treatment, sooner.

Jump Down:

Testing Comparison

GenoPredicta Results

GenoPredicta Advantage

How to Access

For Caregivers

FAQs

check_circle

A Better Way:

GenoPredicta^™

GenoPredicta uses whole-genome sequencing rather than targeted gene panels to get a comprehensive picture of the cancer genome.

What Makes it Different:

Works from a routine blood draw or bone marrow sample
Detects a full spectrum of genetic changes – not just select targets
Provides your doctor the information to understand your disease and how it might respond to treatment

The test uses GenoPredicta to understand your disease and the alterations driving it – giving you and your care team the clearest possible picture.

GENOPREDICTA Insights

What the Test Tells Your Doctor

signal_cellular_alt

Risk Level

Tells your treatment team how aggressive your myeloma is likely to be, so they can choose the most appropriate therapy.

medication

Treatment Fit

Identifies which therapies – including newer immune-based treatments like CAR-T or bispecific antibodies – are most likely to work for your specific disease.

monitor_heart

Disease Monitoring

Tracks measurable residual disease (MRD) with ultra-high sensitivity, helping your doctor assess whether treatment is working over time.

radar

Early Detection

Monitors for signs of disease progression at the earliest possible moment, stay ahead of relapse.

The GenoPredicta Advantage

target

Understand Risk

Helps identify how aggressive the cancer may be.

pill

Guide Treatment

Provides information to help choose the most appropriate therapy.

trending_up

Monitor Progress

Tracks changes in the cancer over time through simple blood test.

water_drop

Assess Response

Future testing may help determine how completely treatment is working.

Get GENOPREDICTA

How to Access

GenoPredicta is available through your physician. If you are being treated for or evaluated for multiple myeloma, ask your doctor if GenoPredicta is right for you.

The Test Is:

Available through ordering clinicians across the US
Accepted during a standard clinical blood draw or bone marrow sample

For Physicians

favorite

For Caregivers and Advocates

If you are supporting a loved one with multiple myeloma, Predicta Biosciences is here to help. Our test gives both patients and their care teams a more complete understanding of the disease – so every treatment decision is made with the best possible information.

Frequently Asked Questions

What Kind of Sample Do I Need to Provide?

We offer the option of using either a blood or bone marrow sample. GenoPredicta™ is an advanced test that provides results from blood with similarly high accuracy as from bone marrow, but with less discomfort and invasiveness.

What Will the GenoPredicta™ Report Tell Me?

The report will show genetic changes that have been detected in your myeloma cells. It may also include information about how your cancer might respond to different treatments.

Is the Test Available in My State?

The test is available in all states except New York. We’re actively working to expand access.

How Does My Doctor Order the Test?

The test must be ordered by a licensed medical provider, who will need to complete a Test Requisition Form (TRF). You can get the form here or by emailing [email protected]. A test kit is required to complete the TRF and will be mailed to you and/or your provider. Licensed medical professionals can also submit TRFs online using Docusign. Sending a copy of the TRF in advance is optional, but it can help our lab team with planning.

Do You Need My Medical Records?

We request recent clinical notes/summary (including treatment history, prior histologic, and cytogenetic findings, and FISH results if available) to take into consideration in the GenoPredicta™ report and aid in the pathologist’s review.

Do I Need to Include My Insurance Information?

Predicta has launched an Early Access Program for its GenoPredicta™ assay. For the duration of this program, Predicta will bill neither public nor private insurers.

How Much Does the Test Cost?

Currently, GenoPredicta™ is part of an Early Access Program, so there is no cost for patients.

How Long Will it Take to Get My Results?

The average report will be delivered within 7-14 days.

How Can I Learn More?

Your voice

Share Your Story

Every myeloma journey is different, and yours could help someone facing what you’re facing now. Whether it’s the moment of diagnosis, a decision along the way, or simply how you keep going, your experience can bring comfort and hope to others. Share your story and become part of a community shaping the future of care.

Connect With Us